Zobrazeno 1 - 10 of 12 pro vyhledávání: '"Kathryn Dumas"'
2
Impact of a Clinical Genomics Program on Trial Accrual for Targeted Treatments: Practical Approach Overcoming Barriers to Accrual for Underserved Patients
Autor: Carol J. Farhangfar, Gregory T. Scarola, Victoria A. Morris, Farhang Farhangfar, Kathryn Dumas, James Symanowski, Jimmy J. Hwang, Kathryn F. Mileham, Daniel R. Carrizosa, R. Wendel Naumann, Chad Livasy, Edward S. Kim, Derek Raghavan
Publikováno v: JCO clinical cancer informatics. 6
PURPOSE Clinical trials of novel and targeted agents increasingly require biomarkers for eligibility. Precision oncology continues to evolve, but challenges hamper broad use of molecular profiling (MP) that could increase the number of patients benef
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::174aebd5509724536d208dbd3c06e268
https://pubmed.ncbi.nlm.nih.gov/35839431
Zobrazit plný text záznamu
6
Pulmonary Carcinosarcoma: A Surveillance, Epidemiology, and End Results (SEER) Analysis
Autor: Yimei Han, Alexander Howard, Edward S. Kim, William A. Ahrens, James T. Symanowski, Elyssa Kim, Kathryn Dumas, Jennifer L. Ersek
Publikováno v: Clinical Lung Cancer. 21:160-170
Pulmonary carcinosarcoma (PC) is a rare malignant neoplasm composed of epithelial and mesenchymal components. It accounts for 1% of thoracic cancers and is not fully understood. This study examined Surveillance, Epidemiology, and End Results (SEER) d
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f593c384e318eece0b312a0fa48d3ac6
https://doi.org/10.1016/j.cllc.2019.07.001
Zobrazit plný text záznamu
7
Paraneoplastic nodular regenerative hyperplasia of the liver associated with placental site trophoblastic tumor
Autor: Carrie L. Langstraat, Jessica Dillon, MaryAnn B. Wilbur, Amanda N. Fader, Deyin Xing, Kathryn Dumas, Rebecca L. Stone, William A. Cliby
Publikováno v: Gynecologic Oncology Reports
Highlights • NRH-L is a rare disease that may lead to non-cirrhotic portal hypertension. • NRH-L may present as a paraneoplastic disorder, complicating oncologic treatment. • This is the first case of NRH-L as a potential paraneoplastic disorde
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47e24efb6c7d60f46f8d237a0e37bc7c
https://doi.org/10.1016/j.gore.2019.05.003
Zobrazit plný text záznamu
9
The impact of a universal inpatient palliative care consultation protocol for patients with gynecologic cancer: a quality improvement project
Autor: Rebecca L. Stone, Anna Beavis, Payam Katebi Kashi, Danielle J. Doberman, Kathryn Dumas, Amanda N. Fader, James Stuart Ferriss, Mali Schneiter, Stephanie L. Wethington
Publikováno v: Gynecologic Oncology. 162:S293
Objectives: The American Society of Clinical Oncology (ASCO) recommends early palliative care assessment (PCA) for patients with advanced or recurrent malignancy. We report initial findings of a protocol designed to meet this standard. Methods: We us
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::754a887b9c32c27d468003af7dbb4ddc
https://doi.org/10.1016/s0090-8258(21)01209-9
Zobrazit plný text záznamu
10
Activity of sequential therapies (txs) in patients (pts) with castration resistant prostate cancer (CRPC) previously treated with galeterone
Autor: Jennifer Roberts, Khalid Mamlouk, Kathryn Dumas, Lillian Werner, Matthew Fiorillo, Rana R. McKay, Mary-Ellen Taplin
Publikováno v: Journal of Clinical Oncology. 33:e16072-e16072
e16072 Background: Galeterone inhibits prostate cancer growth via: 1) irreversible and selective CYP17 inhibition, 2) competitive antagonism of the androgen receptor (AR), and 3) AR protein degrada...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f1b637160b76df8a241b152f00ccc6af
https://doi.org/10.1200/jco.2015.33.15_suppl.e16072
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje